This inventor holds 3 USPTO granted patents. Top assignee: Chiron Corporation. Active years: 1999-2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999-2006
Title: Byung S Suh: Innovator in Viral Protein Translation Control
Introduction
Byung S Suh is a notable inventor based in Lafayette, CA (US). He has made significant contributions to the field of viral research, particularly in the control of translation of viral proteins. With a total of 3 patents to his name, Suh's work has implications for the treatment of viral infections.
Latest Patents
Suh's latest patents focus on methods and compositions for controlling the translation of HCV proteins. These embodiments feature innovative methods and compositions that target the translation of viral peptides and proteins from viral nucleic acid. The applications of his work extend to pestivirus and HCV, utilizing control elements of the 5'UT region of the viral genome.
Career Highlights
Throughout his career, Suh has been associated with Chiron Corporation, where he has contributed to groundbreaking research in virology. His expertise in the field has positioned him as a key figure in the development of therapeutic strategies against viral diseases.
Collaborations
Suh has collaborated with esteemed colleagues, including Jang Hyun Han and Richard R Spaete. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to significant advancements in their research endeavors.
Conclusion
Byung S Suh's work in controlling the translation of viral proteins represents a vital contribution to the field of virology. His patents and collaborations highlight his commitment to advancing scientific knowledge and developing effective treatments for viral infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
